The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety

Abstract Metabolic syndrome (MetS) is associated with depression, but its role in major depressive disorder comorbid with anxiety (AMD) is unclear. This study aimed to investigate the prevalence and clinical correlates of MetS in first-episode drug-naive (FEDN) patients with AMD in a Chinese Han pop...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yinghua Zhong, Manji Hu, Qiang Wang, Zhendong Yang, Na Zhu, Fei Wang, Xiyan Zhang, Chengfang Zhang, Jie Min, Hao Wang, Fazhan Chen, Xudong Zhao, Xiangyang Zhang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/45b407d966274a698231bc0218835bcc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:45b407d966274a698231bc0218835bcc
record_format dspace
spelling oai:doaj.org-article:45b407d966274a698231bc0218835bcc2021-12-02T12:14:56ZThe prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety10.1038/s41598-021-81653-22045-2322https://doaj.org/article/45b407d966274a698231bc0218835bcc2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81653-2https://doaj.org/toc/2045-2322Abstract Metabolic syndrome (MetS) is associated with depression, but its role in major depressive disorder comorbid with anxiety (AMD) is unclear. This study aimed to investigate the prevalence and clinical correlates of MetS in first-episode drug-naive (FEDN) patients with AMD in a Chinese Han population. In total, 1380 FEDN outpatients with AMD were recruited in this cross-sectional study. The sociodemographic features, clinical characteristics, history of suicide attempts, thyroid-stimulating hormone (TSH) levels, and MetS parameters of each subject were evaluated. All subjects were rated on the Hamilton Depression Rating Scale (HAM-D), Hamilton Anxiety Rating Scale (HAM-A), and the Positive and Negative Syndrome Scale positive symptom subscale. The prevalence of MetS among AMD patients was 8.04%. Compared to the non-MetS group, age, age of onset, TSH level, HAM-A and HAM-D scores, history of attempted suicide, and comorbid psychiatric symptoms were higher in the MetS group. Those in this group were also more likely to be married, and they had a lower educational level. Furthermore, age, psychiatric symptoms, suicide attempts, and higher TSH levels were independently associated with MetS in AMD patients. This study suggests a lower prevalence of MetS in FEDN patients with AMD in a Chinese Han population. Older age, comorbid psychiatric symptoms, history of attempted suicide, and higher TSH levels are related factors for MetS in AMD patients.Yinghua ZhongManji HuQiang WangZhendong YangNa ZhuFei WangXiyan ZhangChengfang ZhangJie MinHao WangFazhan ChenXudong ZhaoXiangyang ZhangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yinghua Zhong
Manji Hu
Qiang Wang
Zhendong Yang
Na Zhu
Fei Wang
Xiyan Zhang
Chengfang Zhang
Jie Min
Hao Wang
Fazhan Chen
Xudong Zhao
Xiangyang Zhang
The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety
description Abstract Metabolic syndrome (MetS) is associated with depression, but its role in major depressive disorder comorbid with anxiety (AMD) is unclear. This study aimed to investigate the prevalence and clinical correlates of MetS in first-episode drug-naive (FEDN) patients with AMD in a Chinese Han population. In total, 1380 FEDN outpatients with AMD were recruited in this cross-sectional study. The sociodemographic features, clinical characteristics, history of suicide attempts, thyroid-stimulating hormone (TSH) levels, and MetS parameters of each subject were evaluated. All subjects were rated on the Hamilton Depression Rating Scale (HAM-D), Hamilton Anxiety Rating Scale (HAM-A), and the Positive and Negative Syndrome Scale positive symptom subscale. The prevalence of MetS among AMD patients was 8.04%. Compared to the non-MetS group, age, age of onset, TSH level, HAM-A and HAM-D scores, history of attempted suicide, and comorbid psychiatric symptoms were higher in the MetS group. Those in this group were also more likely to be married, and they had a lower educational level. Furthermore, age, psychiatric symptoms, suicide attempts, and higher TSH levels were independently associated with MetS in AMD patients. This study suggests a lower prevalence of MetS in FEDN patients with AMD in a Chinese Han population. Older age, comorbid psychiatric symptoms, history of attempted suicide, and higher TSH levels are related factors for MetS in AMD patients.
format article
author Yinghua Zhong
Manji Hu
Qiang Wang
Zhendong Yang
Na Zhu
Fei Wang
Xiyan Zhang
Chengfang Zhang
Jie Min
Hao Wang
Fazhan Chen
Xudong Zhao
Xiangyang Zhang
author_facet Yinghua Zhong
Manji Hu
Qiang Wang
Zhendong Yang
Na Zhu
Fei Wang
Xiyan Zhang
Chengfang Zhang
Jie Min
Hao Wang
Fazhan Chen
Xudong Zhao
Xiangyang Zhang
author_sort Yinghua Zhong
title The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety
title_short The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety
title_full The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety
title_fullStr The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety
title_full_unstemmed The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety
title_sort prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/45b407d966274a698231bc0218835bcc
work_keys_str_mv AT yinghuazhong theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT manjihu theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT qiangwang theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT zhendongyang theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT nazhu theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT feiwang theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT xiyanzhang theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT chengfangzhang theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT jiemin theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT haowang theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT fazhanchen theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT xudongzhao theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT xiangyangzhang theprevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT yinghuazhong prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT manjihu prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT qiangwang prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT zhendongyang prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT nazhu prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT feiwang prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT xiyanzhang prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT chengfangzhang prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT jiemin prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT haowang prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT fazhanchen prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT xudongzhao prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
AT xiangyangzhang prevalenceandrelatedfactorsofmetabolicsyndromeinoutpatientswithfirstepisodedrugnaivemajordepressioncomorbidwithanxiety
_version_ 1718394570246455296